Impacto de la infección por el nuevo coronavirus en los pacientes con uveítis asociada a una enfermedad autoinmune: resultado de la encuesta COVID-19-GEAS pacientes
- P. Fanlo 1
- G. Espinosa 2
- A. Adán 2
- R. Arnáez 1
- A. Fonollosa 3
- H. Heras 1
- J. Oteiza 1
- B. del Carmelo Gracia Tello 4
- L. Sáez Comet 5
- L. Pallarés 6
-
1
Hospital Virgen del Camino
info
-
2
Hospital Clinic Barcelona
info
-
3
Hospital de Cruces
info
-
4
Hospital Clínico Universitario Lozano Blesa
info
-
5
Hospital Miguel Servet
info
-
6
Hospital Universitario Son Espases
info
ISSN: 0365-6691
Año de publicación: 2021
Volumen: 96
Número: 7
Páginas: 347-352
Tipo: Artículo
Otras publicaciones en: Archivos de la Sociedad Española de Oftalmologia
Objetivos de desarrollo sostenible
Resumen
Introduction The objetive of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey. Material and methods Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population. Results A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and caucasian (82%), with a mean age of 48 years. The most frequent SAEs were Behçet's disease followed by sarcoidosis and systemic lupus erythematosus. 46% of the patients were receiving corticosteroid treatment at a mean prednisone dose of 11 mg/day. Regarding infection, 14 (50%) patients reported symptoms compatible with SARS-CoV-2 infection. RT-PCR was performed on the nasopharyngeal smear in two patients and in one of them (4%) it was positive. Conclusions Both asymptomatic and symptomatic COVID-19 patients with ASD-associated UNI had received similar immunosuppressive treatment.